BUDESONIDE/ FORMOTEROL FUMARATE DIHYDRATE INHALER (GoResp Digihaler®)

Clinical Indication

Asthma & COPD

Comments

Restricted to severe asthma clinic only on a named patient basis

Date of classification

March 2024

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.